CRO Sy­neos Health did­n't hold up its end of the deal in en­roll­ment for FSD Phar­ma's tri­al, ar­bi­tra­tion pan­el finds

The con­tract re­search or­ga­ni­za­tion Sy­neos Health didn’t hold up its end of the deal and use “com­mer­cial­ly rea­son­able ef­forts” when set­ting up a tri­al for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.